Stanford researchers have developed a non-invasive method of assessing chromosomal composition in human embryos at the blastocyst stage, thus potentially improving chances of success following in vitro fertilization (IVF).
Stanford researchers have developed methods for genetic and epigenetic diagnosis of embryos to determine those of which are more likely to be chromosomally normal and advance in development. This assessment method allows selection of healthier embryos for implantation.
Stanford researchers have developed a quantitative, noninvasive, and early predictor of viability at the early embryo and oocyte stage using mechanical biomarkers.